Green Planet Bioengineering Co., Ltd. reported its financial results for the six months ending June 30, 2025, revealing a net loss of $10,945, a decrease from the $17,328 loss recorded during the same period in 2024. The company’s administrative expenses also declined significantly, totaling $10,945 for the first half of 2025 compared to $17,328 in the previous year. Despite these reductions in losses, the company continues to operate at a deficit, with accumulated losses reaching $1,105,699 as of June 30, 2025.

In terms of liabilities, Green Planet's current liabilities increased slightly to $476,079 from $465,134 at the end of 2024. The company has no cash on hand and relies on financial support from a related party, which has advanced $472,579 to cover operational expenses. This reliance raises concerns about the company's ability to continue as a going concern, as indicated in the filing, which highlights the substantial doubt regarding its future viability without securing additional funding or business opportunities.

Operationally, Green Planet remains a public reorganized shell corporation with no active business operations. The company has not engaged in any acquisitions or product launches during the reporting period. The total number of shares outstanding remains unchanged at 20,006,402, and there have been no new issuances of common or preferred stock. The company’s management continues to seek potential business opportunities and funding sources to facilitate future operations, although the timeline for such developments remains uncertain.

Looking ahead, Green Planet's management has expressed intentions to secure adequate funding from future investors to pursue business opportunities as they arise. However, the company acknowledges that its ability to execute these plans is contingent upon market conditions and the identification of viable business prospects. The filing emphasizes that the financial results for the first half of 2025 may not be indicative of future performance, underscoring the inherent risks and uncertainties associated with the company's current operational status.

About Green Planet Bio Engineering Co. Ltd.

About 10-Q Filings

A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.

Key points about the 10-Q:

  • Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
  • Content: It includes:
    • Financial statements showing the company's current financial position
    • Updates from management on the performance and projections of the business
    • Information about potential risks the company faces
    • Details on how the company is run internally
  • Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.